Systemic Chemotherapy for Upper Tract Urothelial Cancer




24.

Sternberg CN, De Mulder PHM, Schornagel JH, Théodore C, Fossa SD, Van Oosterom AT, Witjes F, Spina M, Van Groeningen CJ, de Balincourt C, Collette L, For the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. Randomized phase III trial of high–dose-intensity Methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924. J Clin Oncol. 2001;19(10):2638–46.PubMed


25.

Vassilakopoulou M, de la Motte Rouge T, Colin P, Ouzzane A, Khayat D, Dimopoulos MA, Papadimitriou CA, Bamias A, Pignot G, Nouhaud FX, Hurel S, Guy L, Bigot P, Roumiguie M, Roupret M, French Collaborative National Database on UUT-UCC. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study. Cancer. 2011;117(24):5500–8.PubMedCrossRef

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 3, 2016 | Posted by in UROLOGY | Comments Off on Systemic Chemotherapy for Upper Tract Urothelial Cancer

Full access? Get Clinical Tree

Get Clinical Tree app for offline access